Search

everythinglearnresearchcommunity

for

Search:↓

CD8+ T cells expand significantly in alopecia areata, suggesting new treatment targets.

Expanded CD8+ T cells are linked to Alopecia Areata and may cause relapse after treatment.

Clonally expanded CD8+ T cells cause alopecia areata.

Researchers found a specific immune receptor in patients that causes severe skin reactions to a drug.

Patients with Alopecia areata have fewer specific immune cells that normally regulate the immune system, which may contribute to the condition.

CD8+ T cells are involved in alopecia areata and may cause disease relapse.

Different scaffold patterns improve wound healing and immune response in mouse skin, with aligned patterns being particularly effective.

Using a combination of specific cell cycle regulators is better for safely keeping hair root cells alive indefinitely compared to cancer-related methods.

CD4+ skin cells may be precursors to basal cell carcinoma.

The research mapped diverse cell types in mouse lacrimal glands, aiding understanding of gland biology and diseases.

Alopecia areata involves specific immune cells, offering potential treatment targets.

Blocking Janus kinase 1 helps stop inflammation and regrow hair, making it a good treatment for hair loss from alopecia areata.

A specific type of immune cell plays a key role in causing alopecia areata and could be a target for treatment.

Tofacitinib helped most patients with alopecia areata regrow hair and changes in immune cells were linked to the treatment's effectiveness.

PINK1 is important for controlling gut immune responses linked to early Parkinson's disease.

Vitiligo is influenced by genetics and environment, and combining these factors can improve early detection and prevention.

An 11-year-old child with total hair loss may have a genetic autoimmune disease, and the outlook for hair regrowth is not good.

Folliculotropic mycosis fungoides has unique molecular features and cell interactions that could guide targeted therapy.

PCFCL may have unrecognized subtypes and needs more research.

TSLP affects atopic dermatitis by increasing sebum and reducing fat through IL-4/IL-13 signaling.

In alopecia areata, certain immune cells increase and express a protein linked to immune activation.

Genetic defects in the glucocorticoid receptor gene can cause conditions with abnormal sensitivity to stress hormones, and other factors may also affect this sensitivity.

MAIT cells may help fight COVID-19 but also contribute to severe inflammation.

Targeting JAK-STAT1 can reduce inflammation and promote hair growth in conditions linked to EGFR deficiency.

Canine pemphigus foliaceus involves significant immune activity and shares similarities with human pemphigus.

Alopecia areata may be treated by using EGCG to balance immune cells and reduce inflammation.

New research is helping develop better treatments for alopecia areata.

ATP-dependent chromatin-remodeling complexes are crucial for gene regulation, cell differentiation, and organ development in mammals.

Alopecia areata is an autoimmune disease causing patchy hair loss, often with other autoimmune disorders, but its exact causes are unknown.

CRAC channels are crucial for the development and function of specialized immune cells, preventing severe inflammation and autoimmune diseases.